Abstract
Summary November 2018, the period covered by this article, showed strong activity in mergers/acquisitions and collaborations, including the announcement of a deal for the global manufacture of a micellar nanoparticulate formulation of paclitaxel. The month also brought positive clinical trial news in therapeutic areas such as pancreatic cancer using CAR-T therapies and asthma. In regulatory news, the US FDA issued a warning highlighting concerns about the serious complications that can occur when using unapproved painkillers with implantable drug pumps and approval was announced for an oral film formulation to treat Lennox-Gastaut syndrome. November also saw patents being issued on novel therapeutic delivery methods for ocular delivery and the use of proprietary vitamin A-micellar delivery vehicle. Information sources used in compiling this update included company press releases and other news websites.
| Original language | English |
|---|---|
| Pages (from-to) | 143-150 |
| Number of pages | 8 |
| Journal | Therapeutic Delivery |
| Volume | 10 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 2019 |
| Externally published | Yes |
Keywords
- competitor intelligence
- emerging technologies
- personalized delivery
